Diabetes

JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes

The Centers for Medicare & Medicaid Services have determined CGMs to be durable medical equipment, a category of devices that can be covered by Medicare

Read More

Medtronic, Insulet Lead Insulin Pump Market in Europe Fueled by Favorable Reimbursement Rates and Increased Adoption

The diabetes monitoring, treatment and drug delivery market in Europe is expected to reach a market value of €9.5 billion by 2022; the market for insulin pumps comprises the traditional insulin pump segment and the insulin patch pump market.

Read More

Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management

New iPro(TM)2 myLog App Collects Data from Continuous Glucose Monitors (CGM) and Fitbit Activity Trackers, Provides Meaningful Insights on How Exercise Impacts Glucose Levels.

Read More

Sanofi, Novo Nordisk, Eli Lilly Lead in Competitive Billion Dollar U.S. Diabetes Device Market

The diabetes monitoring, treatment and drug delivery market in the U.S. is expected to increase to over $25 billion by 2023. Growth in the U.S. diabetes market is expected to persist over the next several years.

Read More

Johnson & Johnson Warns Diabetic Patients About Insulin Pump Vulnerable to Hacking

Johnson & Johnson is warning patients about a security loophole that can leave them vulnerable to overdosing on insulin. The warnings were mailed to 114,000 customers throughout the United States and Canada, as well as doctors who might prescribe the device.

Read More

Novo Nordisk, Sanofi Lead European Diabetes Device Market due to Technological Advancements

The diabetes diagnosis, treatment and drug delivery market is expected to reach a market value of €9.5 billion by 2022. Market growth will be driven by the increasing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin pumps and CGM.

Read More

European Diabetes Care Market Shaped By Innovation, Shifting Competitive Landscape

The European market for diabetes monitoring, treatment, and drug delivery currently is undergoing significant changes in response to technological innovation, pricing pressure, and an expanding competitive landscape.

Read More

New Painless Breath Device Means Diabetics No Longer Have to Endure Daily Finger Pricks

A painless breath test could replace the daily finger prick check for diabetics after scientists found a chemical which rises when blood sugar is too low. the discovery means they could screen for it in a breath test meaning the 400,000 people in Britain living with Type 1 diabetes would not need to draw blood daily.

Read More

Omnis Health EmbracePRO Diabetes System Now Available to Retail Pharmacies

Introduction of EmbracePRO™ System, once available only to healthcare professionals, is now available to retail pharmacies; delivers high-performance, low-cost testing to help pharmacies grow the overall blood glucose monitoring segment.

Read More

New Diabetes Monitoring Device Provides Real-Time Glucose Readings

A new medical device is revolutionising diabetes management in New Zealand and helping to ward off dangerous hypoglycaemic events by sending real-time glucose readings from someone with diabetes straight to a smart device.

Read More